-
BEHIND THE COMPARISON: ARE FEASIBILITY ASSESSMENTS ADEQUATELY REPORTED IN PUBLISHED ITCS?
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS ANALYSIS OF RECATICIMAB VERSUS TAFOLECIMAB FOR PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA IN CHINA
Aug 11, 2026, 17:16 PM -
COMPARATIVE EVALUATION OF HEMATOLOGICAL PARAMETERS FOR DIAGNOSTIC ACCURACY IN RHEUMATOID ARTHRITIS
Aug 11, 2026, 17:16 PM -
WILL THE NEW NATIONAL HEALTHTECH ACCESS PROGRAMME (NHAP) IMPROVE ACCESS FOR DIGITAL PRODUCTS IN ENGLAND AND WALES? A REVIEW OF DIGITAL PRODUCT SUCCESS TO DATE
Aug 11, 2026, 17:16 PM -
FORECASTING THE FUTURE BURDEN OF CELIAC DISEASE IN HUNGARY: A POPULATION-BASED EPIDEMIOLOGICAL ANALYSIS, 2012-2034
Aug 11, 2026, 17:16 PM -
PIPELINE REVIEW OF TRADITIONAL SMALL MOLECULE ANTIBACTERIAL MEDICINES
Aug 11, 2026, 17:16 PM -
CAN A MODEL EXPLAINER AGENT ACCELERATE MANUFACTURER RESPONSES TO HEALTH TECHNOLOGY ASSESSMENT CLARIFICATION QUESTIONS?
Aug 11, 2026, 17:16 PM -
CHARACTERIZING THE CLINICAL AND HUMANISTIC BURDEN OF MYELOFIBROSIS: EVIDENCE FROM A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
CONSTRUCT VARIATION OF TRIAL ENDPOINTS ACROSS FDA-APPROVED NSCLC THERAPIES
Aug 11, 2026, 17:16 PM -
PERFORMANCE OF AI-ASSISTED DATA EXTRACTION ACROSS ECONOMIC SYSTEMATIC LITERATURE REVIEW CATEGORIES: A CASE STUDY IN CHRONIC LYMPHOCYTIC LEUKAEMIA
Aug 11, 2026, 17:16 PM -
AI-SUPPORTED REIMBURSEMENT COMMUNICATION FOR PHARMACEUTICAL SALES TEAMS: A REAL-WORLD IMPLEMENTATION BY MARS AND HEALTHMIND
Aug 11, 2026, 17:16 PM -
WHEN IS IT SAFE FOR MEN AGED =65 YEARS WITH AN ABDOMINAL AORTIC ANEURYSM (AAA) TO EXIT FROM SCREENING? AN EVIDENCE MAP AND SUBSEQUENT RAPID REVIEW
Aug 11, 2026, 17:16 PM -
HOW MANY PATIENTS DOES A MICROSIMULATION NEED? CONVERGENCE IN PATIENT-LEVEL SIMULATION, AND THE DIMINISHING MARGINAL BENEFIT OF SIZE
Aug 11, 2026, 17:16 PM -
THE GLOBAL RIPPLE EFFECT OF US DRUG PRICING REFORMS: MANUFACTURER STRATEGIES, PAYER COUNTER-OFFENSIVES, AND HEOR TRANSFORMATION EX-US
Aug 11, 2026, 17:16 PM -
TEPROTUMUMAB FOR THYROID EYE DISEASE: UK KEY OPINION LEADER PERSPECTIVES TO INFORM A NICE HTA STRATEGY
Aug 11, 2026, 17:16 PM -
CAREGIVER IMPACTS OF ACUTE AND CHRONIC MIGRAINE: A LITERATURE-BASED CONCEPTUAL MODEL
Aug 11, 2026, 17:16 PM -
PATIENT-LEVEL SIMULATIONS IN NICE TECHNOLOGY APPRAISALS: HOW OFTEN ARE THEY USED AND WHY ARE THEY CHOSEN?
Aug 11, 2026, 17:16 PM -
MEASUREMENT PROPERTIES OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD): A GLOBAL STUDY OF PATIENTS WITH ALOPECIA AREATA
Aug 11, 2026, 17:16 PM -
ESTABLISHING NON-INFERIORITY OF RITUXIMAB PLUS LENALIDOMIDE IN THE TREATMENT OF ADVANCED PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
Aug 11, 2026, 17:16 PM -
FIVE-YEAR BLOOD PRESSURE TRAJECTORIES AND CUMULATIVE RISK OF SEVERELY UNCONTROLLED HYPERTENSION IN 67764 HYPERTENSIVE PATIENTS
Aug 11, 2026, 17:16 PM
